Cargando…
A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects
The inherent instability of nucleic acids within serum and the tumor microenvironment necessitates a suitable vehicle for non-viral gene delivery to malignant lesions. A specificity-conferring mechanism is also often needed to mitigate off-target toxicity. In the present study, we report a stable an...
Autores principales: | Cheng, Bei, Ahn, Hye-Hyun, Nam, Hwanhee, Jiang, Zirui, Gao, Feng J., Minn, Il, Pomper, Martin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878887/ https://www.ncbi.nlm.nih.gov/pubmed/35214105 http://dx.doi.org/10.3390/pharmaceutics14020373 |
Ejemplares similares
-
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021) -
Fabrication and Characterization of Chitosan/Poly(Lactic-Co-glycolic Acid) Core-Shell Nanoparticles by Coaxial Electrospray Technology for Dual Delivery of Natamycin and Clotrimazole
por: Cui, Xiaoming, et al.
Publicado: (2021) -
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
por: Ahn, Hye-Hyun, et al.
Publicado: (2021) -
Size-dependent bioactivity of electrosprayed core–shell chitosan-alginate particles for protein delivery
por: Shamszadeh, Sayna, et al.
Publicado: (2022) -
Hard-Shelled Glycol Chitosan Nanoparticles for Dual MRI/US Detection of Drug Delivery/Release: A Proof-of-Concept Study
por: Baroni, Simona, et al.
Publicado: (2023)